tiprankstipranks
Trending News
More News >
Sleep Number Corp (SNBR)
:SNBR
Advertisement

Sleep Number (SNBR) AI Stock Analysis

Compare
444 Followers

Top Page

SNBR

Sleep Number

(NASDAQ:SNBR)

Select Model
Select Model
Select Model
Underperform 39 (OpenAI - 4o)
Rating:39Underperform
Price Target:
$5.00
▼(-21.51% Downside)
Sleep Number's overall stock score is primarily impacted by its weak financial performance, characterized by declining revenues, negative profitability, and high leverage. Technical analysis also indicates bearish momentum, with the stock trading below key moving averages and showing oversold conditions. Valuation metrics are poor, with a negative P/E ratio and no dividend yield, reflecting financial instability rather than market mispricing. While the earnings call suggests potential future improvements, current challenges dominate the outlook.

Sleep Number (SNBR) vs. SPDR S&P 500 ETF (SPY)

Sleep Number Business Overview & Revenue Model

Company DescriptionSleep Number Corporation (SNBR) is a leading American mattress and bedding company that specializes in innovative sleep solutions. The company operates in the home furnishings sector, primarily focusing on the design, manufacture, and retail of adjustable air mattresses and related products. Sleep Number's core offerings include its proprietary Sleep Number beds, which allow customers to customize firmness and support through air chambers controlled via a smartphone app or remote. Additionally, the company provides bedding accessories, sleep management tools, and technology-driven sleep solutions aimed at enhancing overall sleep quality.
How the Company Makes MoneySleep Number generates revenue through multiple key streams, primarily from the sale of its adjustable air mattresses and smart beds, which are marketed directly to consumers through its retail stores and online platforms. The company also earns income from the sale of sleep accessories, including pillows, sheets, and mattress protectors. A significant part of its revenue comes from the direct-to-consumer approach, which allows for higher margins compared to traditional retail models. Furthermore, Sleep Number has developed partnerships with various health and wellness organizations, leveraging data analytics to enhance its product offerings and customer experience. These initiatives, coupled with ongoing investments in technology and innovation, contribute to its overall earnings and customer retention strategies.

Sleep Number Earnings Call Summary

Earnings Call Date:Sep 27, 2025
(Q3-2025)
|
Next Earnings Date:Feb 25, 2026
Earnings Call Sentiment Neutral
The earnings call highlighted significant financial restructuring and cost reduction efforts, which are expected to support future growth. However, the company's current financial performance, including a notable decline in sales and profits, reflects ongoing challenges in the competitive landscape.
Q3-2025 Updates
Positive Updates
Bank Agreement Extension
Secured an amendment and extension of the bank agreement through 2027, providing financial flexibility to focus on sales-driving initiatives and execute the turnaround strategy.
Cost Reduction Achievements
Reduced operating expenses, excluding restructuring and nonrecurring costs, by $115 million with an expectation to exceed the $130 million cost-out target for 2025.
Marketing Efficiency Improvements
Achieved a 6% decline in cost per acquisition versus the prior year, with improvements in marketing efficiency expected to drive increased traffic in the future.
Negative Updates
Q3 Revenue Decline
Net sales of $343 million were down 19.6% year-over-year, driven by reduced marketing and media investments and increased competition.
Profit and Cash Flow Below Expectations
Profits and cash flow were well below expectations, resulting in a reduction of full year net sales, adjusted EBITDA, and free cash flow expectations.
Gross Profit Margin Decline
Gross profit margin was 59.9%, down 93 basis points versus last year, mainly due to unit volume deleverage.
Restructuring and Nonrecurring Costs
Recorded $41 million in restructuring and other nonrecurring costs in Q3, with significant noncash charges related to asset impairments.
Company Guidance
During the Q3 2025 earnings call, Sleep Number provided guidance that emphasized a strategic turnaround aimed at stabilizing and growing sales in 2026. The company reported a 19.6% decline in Q3 net sales to $343 million, with a gross profit margin of 59.9%. Operating expenses, excluding restructuring costs, fell by 18% year-over-year to $204 million. Despite a challenging competitive environment and media spend reductions of 32% in Q2 and Q3, Sleep Number is optimistic about future prospects. They secured an amendment to their bank agreement through 2027, allowing for increased financial flexibility to invest in growth initiatives. The company expects full-year 2025 net sales of approximately $1.4 billion, with adjusted EBITDA of around $70 million and a negative free cash flow of approximately $50 million. Looking ahead, Sleep Number plans to simplify its product offerings, enhance marketing strategies, optimize its distribution model, and continue cost reduction efforts, including a focus on real estate consolidation, to drive improved financial performance in 2026.

Sleep Number Financial Statement Overview

Summary
Sleep Number is experiencing significant financial challenges, including declining revenues, negative profitability, high leverage, and liquidity issues. The company's financial health is under pressure, with negative equity and insufficient cash flow generation to support operations and investments.
Income Statement
43
Neutral
Sleep Number's current TTM revenue has decreased compared to the previous annual report, indicating a declining growth trajectory. Gross Profit Margin is healthy at approximately 60.3%, but the company is currently operating at a net loss, with a negative Net Profit Margin of -2.7%. EBIT and EBITDA margins are also quite low, reflecting challenges in profitability and operational efficiency.
Balance Sheet
30
Negative
The company has a negative stockholder's equity, indicating financial instability. The Debt-to-Equity ratio is not calculable due to negative equity, but the high total debt levels relative to assets signal significant leverage. Return on Equity (ROE) is not meaningful due to negative equity, and the Equity Ratio is negative, underscoring financial risk.
Cash Flow
35
Negative
Operating cash flow is positive, but the Free Cash Flow is negative, indicating insufficient cash generation to cover capital expenditures. The Operating Cash Flow to Net Income ratio is negative due to negative net income, highlighting profitability challenges. Additionally, Free Cash Flow to Net Income is not favorable, stressing liquidity issues.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2019Dec 2018
Income Statement
Total Revenue1.06B1.68B1.89B2.11B1.70B1.53B
Gross Profit639.67M1.00B1.09B1.20B1.05B927.96M
EBITDA43.24M89.22M95.34M135.28M173.96M154.39M
Net Income-73.45M-20.33M-15.29M36.61M81.84M69.54M
Balance Sheet
Total Assets749.39M860.81M950.88M953.94M806.04M470.14M
Cash, Cash Equivalents and Short-Term Investments1.26M1.95M2.54M1.79M1.59M1.61M
Total Debt940.71M936.11M972.65M896.01M588.65M199.60M
Total Liabilities1.27B1.31B1.39B1.39B965.47M579.69M
Stockholders Equity-521.34M-451.59M-441.93M-438.18M-159.43M-109.55M
Cash Flow
Free Cash Flow-16.73M3.64M-66.08M-33.32M129.92M86.03M
Operating Cash Flow-4.84M27.14M-9.03M36.14M189.16M131.54M
Investing Cash Flow-15.17M-26.29M-58.35M-70.61M-56.62M-45.24M
Financing Cash Flow19.32M-1.44M68.13M33.87M-132.56M-88.34M

Sleep Number Technical Analysis

Technical Analysis Sentiment
Negative
Last Price6.37
Price Trends
50DMA
7.30
Negative
100DMA
7.87
Negative
200DMA
8.92
Negative
Market Momentum
MACD
-0.64
Positive
RSI
25.90
Positive
STOCH
34.68
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SNBR, the sentiment is Negative. The current price of 6.37 is above the 20-day moving average (MA) of 5.94, below the 50-day MA of 7.30, and below the 200-day MA of 8.92, indicating a bearish trend. The MACD of -0.64 indicates Positive momentum. The RSI at 25.90 is Positive, neither overbought nor oversold. The STOCH value of 34.68 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SNBR.

Sleep Number Risk Analysis

Sleep Number disclosed 2 risk factors in its most recent earnings report. Sleep Number reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Sleep Number Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
66
Neutral
$614.02M13.079.96%7.06%-4.61%-25.66%
64
Neutral
$1.33B14.759.09%2.80%2.18%-22.35%
62
Neutral
$1.21B5.5526.20%2.29%-6.03%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
55
Neutral
$1.06B-1.18%4.39%5.37%-127.27%
48
Neutral
$87.51M-1.03-9999.00%-9.47%48.11%
39
Underperform
$120.46M-16.95%-88.00%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SNBR
Sleep Number
4.61
-10.25
-68.98%
ETD
Ethan Allen
23.67
-4.06
-14.64%
MLKN
MillerKnoll
14.28
-9.54
-40.05%
LZB
La-Z-Boy Incorporated
31.41
-10.42
-24.91%
LEG
Leggett & Platt
8.77
-3.05
-25.80%
PRPL
Purple Innovation
0.83
-0.06
-6.74%

Sleep Number Corporate Events

Executive/Board ChangesPrivate Placements and Financing
Sleep Number Amends Credit Agreement, Extends Maturity Date
Neutral
Nov 5, 2025

On November 4, 2025, Sleep Number Corporation executed a Twelfth Amendment to its Credit and Security Agreement, extending the maturity date to December 3, 2027, and adjusting various financial covenants and credit facilities. This amendment signifies a strategic financial restructuring for the company, ensuring compliance with all covenants and facilitating the retirement of Board member Stephen L. Gulis, Jr., who stepped down following the amendment’s qualification as a debt refinancing.

The most recent analyst rating on (SNBR) stock is a Sell with a $5.00 price target. To see the full list of analyst forecasts on Sleep Number stock, see the SNBR Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 08, 2025